-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
GlobeStar Therapeutics Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q4 2023.
- GlobeStar Therapeutics Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$42.8K, a 9.35% decline year-over-year.
- GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$206K, a 37.1% increase from 2022.
- GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$327K, a 56.5% increase from 2021.
- GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$751K, a 213% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)